{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:08:22Z","timestamp":1788599302827,"version":"build-2803163510"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Purpose:<\/jats:bold> Nanoparticles (NPs) of the polydopamine (PDA)-based,loaded with temozolomide (TMZ) and conjugated with Pep-1 (Peptide-1) as a feasible nano-drug delivery system were constructed and utilized for chemotherapy (CT) and photothermal therapy (PTT) of glioblastoma (GBM).<\/jats:p><jats:p><jats:bold>Method:<\/jats:bold> PDA NPs were synthesized from dopamine (DA) hydrochloride and reacted with TMZ to obtain the PDA-TMZ NPs and then the PDA NPs and the PDA-TMZ NPs were conjugated and modified by Pep-1 to obtain the Pep-1@PDA NPs and Pep-1@PDA-TMZ NPs <jats:italic>via<\/jats:italic> the Schiff base reaction (SBR), respectively.Their dimensions, charge, and shape were characterized by dynamic light scattering (DLS) and scanning electron microscope (SEM). The assembly of TMZ was verified by Fourier-transform infrared spectroscopy (FT-IR) and ultraviolet and visible spectroscopy (UV-Vis). The biostability of both the nanocarrier and the synthetic NPs were validated using water and fetal bovine serum (FBS). The antitumor activities of the PDA-TMZ NPs and Pep-1@PDA-TMZ NPs were verified in U87 cells and tumor-bearing nude mice.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The prepared PDA NPs, PDA-TMZ NPs, Pep-1@PDA NPs, and Pep-1@PDA-TMZ NPs were regular and spherical, with dimension of approximately 122, 131, 136, and 140\u00a0nm, respectively. The synthetic nanoparticles possessed good dispersity, stability,solubility, and biocompatibility. No obvious toxic side effects were observed, and the loading rate of TMZ was approximately 50%.<jats:italic>In vitro<\/jats:italic> research indicated that the inhibition ratio of the Pep-1@PDA-TMZ NPs combined with 808\u00a0nm laser was approximately 94% for U87 cells and <jats:italic>in vivo<\/jats:italic> research was approximately 77.13%, which was higher than the ratio of the other groups (<jats:italic>p<\/jats:italic> &amp;lt; 0.05).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Pep-1 was conjugated and modified to PDA-TMZ NPs, which can serve as a new targeted drug nano-delivery system and can offer a CT and PTT integration therapy against GBM. Thus, Pep-1@PDA-TMZ NPs could be a feasible approach for efficient GBM therapy, and further provide some evidence and data for clinical transformation so that gradually conquer GBM.<\/jats:p>","DOI":"10.3389\/fphar.2023.1081612","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T04:54:48Z","timestamp":1674017688000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Polydopamine-based loaded temozolomide nanoparticles conjugated by peptide-1 for glioblastoma chemotherapy and photothermal therapy"],"prefix":"10.3389","volume":"14","author":[{"given":"Hao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengzhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.2174\/0929867324666170516123206","article-title":"Glioblastoma multiforme, diagnosis and Treatment;Recent literature review","volume":"24","author":"Batash","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1080\/10717544.2018.1440447","article-title":"Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy","volume":"25","author":"Bi","year":"2018","journal-title":"Drug Deliv."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.3390\/molecules26113329","article-title":"PEP-1-GLRX1 reduces dopaminergic neuronal cell loss by modulating MAPK and apoptosis signaling in Parkinson's disease","volume":"26","author":"Choi","year":"2021","journal-title":"Mol. (Basel, Switz."},{"key":"B4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1039\/d1bm01482j","article-title":"Glutathione-degradable polydopamine nanoparticles as a versatile platform for fabrication of advanced photosensitisers for anticancer therapy","volume":"10","author":"Dai","year":"2021","journal-title":"Biomaterials Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jconrel.2019.07.036","article-title":"Functionalized theranostic nanocarriers with bio-inspired polydopamine for tumor imaging and chemo-photothermal therapy","volume":"309","author":"Farokhi","year":"2019","journal-title":"J. Control. release official J. Control. Release Soc."},{"key":"B6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fphar.2017.00166","article-title":"Targeted nanotechnology in glioblastoma multiforme","volume":"8","author":"Glaser","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","article-title":"Cell-penetrating peptides: From basic research to clinics","volume":"38","author":"Guidotti","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.xphs.2018.11.046","article-title":"Pep-1&borneol-Bifunctionalized carmustine-loaded micelles enhance anti-glioma efficacy through tumor-targeting and BBB-penetrating","volume":"108","author":"Guo","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.colsurfb.2016.08.002","article-title":"PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma","volume":"147","author":"Jiang","year":"2016","journal-title":"Colloids surfaces. B, Biointerfaces"},{"key":"B10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1021\/acsami.6b13805","article-title":"Enhanced antiglioma efficacy of ultrahigh loading capacity paclitaxel prodrug conjugate self-assembled targeted nanoparticles","volume":"9","author":"Jiang","year":"2017","journal-title":"ACS Appl. Mater. interfaces"},{"key":"B11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.colsurfb.2017.03.058","article-title":"Pep-1 peptide-functionalized liposome to enhance the anticancer efficacy of cilengitide in glioma treatment","volume":"158","author":"Jiao","year":"2017","journal-title":"Colloids surfaces.B, Biointerfaces"},{"key":"B12","doi-asserted-by":"publisher","first-page":"878365","DOI":"10.3389\/fimmu.2022.878365","article-title":"Recent advances in IL-13r\u03b12-directed cancer immunotherapy","volume":"13","author":"Knudson","year":"2022","journal-title":"Front. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"10622","DOI":"10.3390\/ijms221910622","article-title":"Construction of IL-13 receptor \u03b12-targeting resveratrol nanoparticles against glioblastoma cells:therapeutic efficacy and molecular effects","volume":"22","author":"Lin","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/adma.201204683","article-title":"Dopamine-melanin colloidal nanospheres: An efficient near-infrared photothermal therapeutic agent for in vivo cancer therapy","volume":"25","author":"Liu","year":"2013","journal-title":"Adv. Mater. Deerf. Beach, Fla.)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1021\/cr400407a","article-title":"Polydopamine and its derivative materials:synthesis and promising applications in energy, environmental, and biomedical fields","volume":"114","author":"Liu","year":"2014","journal-title":"Chem. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1021\/acs.molpharmaceut.6b00523","article-title":"Enhanced antiglioblastoma efficacy of neovasculature and glioma cells dual targeted nanoparticles","volume":"13","author":"Lv","year":"2016","journal-title":"Mol. Pharm."},{"key":"B17","doi-asserted-by":"publisher","first-page":"12269","DOI":"10.1039\/d0sc04486e","article-title":"Polydopamine-based nanoreactors: Synthesis and applications in bioscience and energy materials","volume":"11","author":"Mei","year":"2020","journal-title":"Chem. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.drudis.2012.03.002","article-title":"Cell-penetrating peptides: Classes, origin, and current landscape","volume":"17","author":"Milletti","year":"2012","journal-title":"Drug Discov. today"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1038\/s41388-018-0596-2","article-title":"Fstl1\/DIP2A\/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma","volume":"38","author":"Nie","year":"2019","journal-title":"Oncogene"},{"key":"B20","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2013-2017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro-oncology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/neuonc\/nor141","article-title":"An interleukin 13 receptor \u03b1 2-specific peptide homes to human Glioblastoma multiforme xenografts","volume":"14","author":"Pandya","year":"2012","journal-title":"Neuro-oncology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"17040","DOI":"10.1038\/sigtrans.2017.40","article-title":"Targeting cellular pathways in glioblastoma multiforme","volume":"2","author":"Pearson","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.nano.2013.10.001","article-title":"Nanotherapeutic approaches for brain cancer management","volume":"10","author":"Saenz del Burgo","year":"2014","journal-title":"Nanomedicine:nanotechnology, Biol. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40820-020-00474-6","article-title":"Molecular design of conjugated small molecule nanoparticles for synergistically enhanced PTT\/PDT","volume":"12","author":"Shao","year":"2020","journal-title":"Nano-micro Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/neuonc\/nou045","article-title":"Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy","volume":"16","author":"Thaci","year":"2014","journal-title":"Neuro-oncology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"16589","DOI":"10.1038\/srep16589","article-title":"Improved anti-glioblastoma efficacy by IL-13R\u03b12 mediated copolymer nanoparticles loaded with paclitaxel","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.biomaterials.2015.11.037","article-title":"Multi-responsive photothermal-chemotherapy with drug-loaded melanin-like nanoparticles for synergetic tumor ablation","volume":"81","author":"Wang","year":"2016","journal-title":"Biomaterials"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1080\/10717544.2017.1378940","article-title":"Glioma and microenvironment dual targeted nanocarrier for improved antiglioblastoma efficacy","volume":"24","author":"Wang","year":"2017","journal-title":"Drug Deliv."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3389\/fphar.2018.01556","article-title":"Enhanced anti-tumor of pep-1 modified superparamagnetic iron oxide\/PTX loaded polymer nanoparticles","volume":"9","author":"Wang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1166\/jbn.2020.2950","article-title":"Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 by conformational analysis","volume":"16","author":"Wang","year":"2020","journal-title":"J. Biomed. Nanotechnol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1021\/acs.molpharmaceut.0c00911","article-title":"Intranasal delivery of temozolomide-conjugated gold nanoparticles functionalized with anti-EphA3 for glioblastoma targeting","volume":"18","author":"Wang","year":"2021","journal-title":"Mol. Pharm."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41551-021-00728-7","article-title":"Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance","volume":"5","author":"Wang","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1021\/acs.molpharmaceut.2c00083","article-title":"Efficacy of temozolomide-conjugated gold nanoparticle photothermal therapy of drug-resistant glioblastoma and its mechanism study","volume":"19","author":"Yu","year":"2022","journal-title":"Mol. Pharm."},{"key":"B34","doi-asserted-by":"publisher","first-page":"8176","DOI":"10.1021\/acsami.5b01027","article-title":"Chlorin e6 Conjugated Poly(dopamine) Nanospheres as PDT\/PTT Dual-Modal Therapeutic Agents for Enhanced Cancer Therapy","volume":"7","author":"Zhang","year":"2015","journal-title":"ACS Appl. Mater. interfaces"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1605094","DOI":"10.1002\/adfm.201605094","article-title":"Biocompatible D-A semiconducting polymer nanoparticle with light-harvesting unit for highly effective photoacoustic imaging guided photothermal therapy","volume":"27","author":"Zhang","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e2000228","DOI":"10.1002\/mabi.202000228","article-title":"Polydopamine-incorporated nanoformulations for biomedical applications","volume":"20","author":"Zheng","year":"2020","journal-title":"Macromol. Biosci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1081612\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T04:54:53Z","timestamp":1674017693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1081612\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":36,"alternative-id":["10.3389\/fphar.2023.1081612"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1081612","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]},"article-number":"1081612"}}